Yaghmur Anan, Mu Huiling
Department of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 2, Copenhagen Ø 2100, Denmark.
Acta Pharm Sin B. 2021 Apr;11(4):871-885. doi: 10.1016/j.apsb.2021.02.013. Epub 2021 Feb 24.
The use of lipid nanocarriers for drug delivery applications is an active research area, and a great interest has particularly been shown in the past two decades. Among different lipid nanocarriers, (Internally self-assembled somes or particles), including cubosomes and hexosomes, and solid lipid nanoparticles (SLNs) have unique structural features, making them attractive as nanocarriers for drug delivery. In this contribution, we focus exclusively on recent advances in formation and characterization of , mainly cubosomes and hexosomes, and their use as versatile nanocarriers for different drug delivery applications. Additionally, the advantages of SLNs and their application in oral and pulmonary drug delivery are discussed with focus on the biological fates of these lipid nanocarriers . Despite the demonstrated advantages in and evaluations including preclinical studies, further investigations on improved understanding of the interactions of these nanoparticles with biological fluids and tissues of the target sites is necessary for efficient designing of drug nanocarriers and exploring potential clinical applications.
脂质纳米载体在药物递送应用中的使用是一个活跃的研究领域,在过去二十年中尤其受到广泛关注。在不同的脂质纳米载体中,内部自组装体(包括立方液晶和六方液晶)以及固体脂质纳米粒具有独特的结构特征,使其作为药物递送的纳米载体具有吸引力。在本文中,我们专门关注内部自组装体(主要是立方液晶和六方液晶)的形成和表征方面的最新进展,以及它们作为用于不同药物递送应用的通用纳米载体的用途。此外,还讨论了固体脂质纳米粒的优势及其在口服和肺部药物递送中的应用,重点关注这些脂质纳米载体的生物学命运。尽管在包括临床前研究在内的安全性和有效性评估中已证明了优势,但为了高效设计药物纳米载体并探索潜在的临床应用,有必要进一步研究以更好地理解这些纳米颗粒与靶部位生物流体和组织之间的相互作用。